Relevant bibliographies by topics / Duchenne / Journal articles
To see the other types of publications on this topic, follow the link: Duchenne.

Journal articles on the topic 'Duchenne'

Author: Grafiati
Published: 4 June 2021
Last updated: 10 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Duchenne.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Senatorova, A., and I. Khodun. "ERB-DUCHENNE PALSY (CASE REPORT)." Inter Collegas 5, no. 2 (July 26, 2018): 80–83. http://dx.doi.org/10.35339/ic.5.2.80-83.

Full text
Abstract:
ERB–DUCHENNE PALSY (case study)Senatorova A.V., Khodun I.I.The frequency of damage to the brachial plexus is 0.5-2 per 1000 live births. Most of them (about 90 % cases) are Erb-Duchesnne palsy. Birth trauma of the brachial plexus occurs mainly in in full-term newborns. Correct diagnosis of Erb-Duchesnne palsy allows to avoid long-term complications as late treatment leads to disability. The article presents a clinical observation of Erb-Duchesnne palsy in a newborn patient, who was diagnosed on the first day of life. Conservative therapy was an effective strategy of baby’s recovery.Key words: Erb-Duchenne palsy, birth injury, brachial plexus, newborn. ПАРАЛІЧ ДЮШЕНА-ЕРБА (клінічний випадок)Сенаторова А.В., Ходун І.І.Частота пошкодження плечового сплетення становить 0,5-2 на 1000 живонароджених; серед них 90% випадків - це параліч Дюшена-Ерба. Причиною його можуть бути травми плечового сплетення у доношених новонароджених під час пологів. Своєчасна діагностика паралічу Дюшена-Ерба дозволяє уникнути відстрочених ускладнень. Несвоєчасне розпочате лікування призводить до інвалідизації. У статті наведено клінічне спостереження паралічу Дюшена - Ерба у новонародженого діагностували в першу добу. Своєчасна розпочата консервативна терапія призвела до одужання дитини.Ключові слова: параліч Ерб-Дюшенна, родова травма, плечове сплетіння, новонароджений. ПАРАЛИЧ ДЮШЕНА-ЭРБА (клинический случай)Сенаторова А.В., Ходун И.И.Частота повреждения плечевого сплетения составляет 0,5-2 на 1000 живорожденных; среди них 90% случаев – это паралич Дюшена-Эрба. Причиной его могут быть травмы плечевого сплетения у доношенных новорожденных во время родов. Своевременная диагностика паралича Дюшена-Эрба позволяет избежать отсроченных осложнений. Несвоевременно начатое лечение приводит к инвалидизации. В статье приведено клиническое наблюдение паралича Дюшена - Эрба у новорожденного, диагностированного в первые сутки. Своевременно начатая консервативная терапия способствовала выздоровлению ребенка.Ключевые слова: паралич Эрб-Дюшенна, родовая травма, плечевое сплетение, новорожденный.
APA, Harvard, Vancouver, ISO, and other styles
2

Goldblatt, David. "A Gentleman of Bologna Duchenne, Duchesne, etc." Seminars in Neurology 8, no. 01 (1988): 115–16. http://dx.doi.org/10.1055/s-2008-1041363.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Parent, André. "Duchenne De Boulogne: A Pioneer in Neurology and Medical Photography." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 32, no. 3 (August 2005): 369–77. http://dx.doi.org/10.1017/s0317167100004315.

Full text
Abstract:
ABSTRACT:Guillaume-Benjamin-Amand Duchenne was born 200 years ago in Boulogne-sur-Mer (Pas-de-Calais, France). He studied medicine in Paris and became a physician in 1831. He practiced general medicine in his native town for about 11 years and then returned to Paris to initiate pioneering studies on electrical stimulation of muscles. Duchenne used electricity not only as a therapeutic agent, as it was commonly the case earlier in the 19th century, but chiefly as a physiological investigation tool to study the anatomy of the living body. Without formal appointment he visited hospital wards across Paris searching for rare cases of neuromuscular disorders. He built a portable electrical device that he used to functionally map all bodily muscles and to study their coordinating action in health and disease. He gave accurate descriptions of many neuromuscular disorders, including pseudohypertrophic muscular dystrophy to which his name is still attached (Duchenne muscular dystrophy). He also invented a needle system (Duchenne's histological harpoon) for percutaneous sampling of muscular tissue without anesthesia, a forerunner of today's biopsy. Duchenne summarized his work in two major treatises entitled De l'électrisation localisée (1855) and Physiologie des mouvements (1867). Duchenne's iconographic work stands at the crossroads of three major discoveries of the 19th century: electricity, physiology and photography. This is best exemplified by his investigation of the mechanisms of human physiognomy in which he used localized faradic stimulation to reproduce various forms of human facial expression. The album that complements his book on this issue is considered a true incunabulum of photography. Duchenne de Boulogne, a shy but hard-working, acute and ingenious observer, became one of most original clinicians of the 19th century. He died in Paris in 1875.
APA, Harvard, Vancouver, ISO, and other styles
4

Lwi, Sandy J., James J. Casey, Alice Verstaen, Dyan E. Connelly, Jennifer Merrilees, and Robert W. Levenson. "Genuine Smiles by Patients During Marital Interactions are Associated with Better Caregiver Mental Health." Journals of Gerontology: Series B 74, no. 6 (January 27, 2018): 975–87. http://dx.doi.org/10.1093/geronb/gbx157.

Full text
Abstract:
Abstract Objective Providing care for a spouse with dementia is associated with an increased risk for poor mental health. To determine whether this vulnerability in caregivers is related to the expression of positive emotion, we examined 57 patients with Alzheimer’s disease and behavioral variant frontotemporal dementia and their spouses as they discussed a marital conflict. Method Facial behavior during the discussion was objectively coded to identify Duchenne (i.e., genuine) smiles and non-Duchenne (i.e., polite) smiles. Caregiver mental health was measured using the Medical Outcomes Survey. Results Greater expression of Duchenne smiles by patients was associated with better caregiver mental health, even when accounting for covariates (i.e., diagnosis, patient cognitive functioning, and caregiver marital satisfaction). Greater expression of non-Duchenne smiles by patients was associated with worse caregiver health, but only when covariates were entered in the model. Expression of Duchenne and non-Duchenne smiles by caregivers was not associated with caregiver mental health. Discussion Patients’ expression of Duchenne and non-Duchenne smiles may reveal important aspects of the emotional quality of the patient–caregiver relationship that influence caregiver burden and mental health.
APA, Harvard, Vancouver, ISO, and other styles
5

Meißner, Thomas. "Duchenne-Muskeldystrophie." MMW - Fortschritte der Medizin 157, no. 13 (July 2015): 81. http://dx.doi.org/10.1007/s15006-015-3369-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sekelj Fureš, J., and V. Đuranović. "Female Duchenne." European Journal of Paediatric Neurology 21 (June 2017): e229. http://dx.doi.org/10.1016/j.ejpn.2017.04.1244.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Thibault, Pascal, Manon Levesque, Pierre Gosselin, and Ursula Hess. "The Duchenne Marker is Not a Universal Signal of Smile Authenticity – But it Can Be Learned!" Social Psychology 43, no. 4 (January 2012): 215–21. http://dx.doi.org/10.1027/1864-9335/a000122.

Full text
Abstract:
The Duchenne marker has been proposed as a universal marker of smile authenticity. However, Elfenbein, Beaupré, Levesque, and Hess (2007 ) found that, whereas Canadians typically show the Duchenne marker when posing happiness, Gabonese do not. We therefore investigated whether the Duchenne marker is perceived as a marker of smile authenticity by Gabonese and by Mainland Chinese living in Quebec, Canada. The results show that Gabonese do not use the Duchenne marker to assess smile authenticity at all. Mainland Chinese immigrants to Quebec showed sensitivity to the Duchenne marker only when judging smiles by French-Canadian encoders, suggesting learning of the use of this cultural dialect through cultural exposure. In sum, the use of Duchenne marker is not universal, but rather limited to certain cultures.
APA, Harvard, Vancouver, ISO, and other styles
8

Soim, Aida, Bailey Wallace, Nedra Whitehead, Michael G. Smith, Joshua R. Mann, Shiny Thomas, and Emma Ciafaloni. "Health Profile of Preterm Males With Duchenne Muscular Dystrophy." Journal of Child Neurology 36, no. 12 (October 2021): 1095–102. http://dx.doi.org/10.1177/08830738211047019.

Full text
Abstract:
In this retrospective cohort study, we characterize the health profile of preterm males with Duchenne muscular dystrophy. Major clinical milestones (ambulation cessation, assisted ventilation use, and onset of left ventricular dysfunction) and corticosteroids use in males with Duchenne muscular dystrophy identified through a population-based surveillance system were analyzed using Kaplan-Meier survival curves and Cox proportional hazards modeling. The adjusted risk of receiving any respiratory intervention among preterm males with Duchenne muscular dystrophy was 87% higher than among the corresponding full-term males with Duchenne muscular dystrophy. The adjusted risks for ambulation cessation and left ventricular dysfunction were modestly elevated among preterm compared to full-term males, but the 95% confidence intervals contained the null. No difference in the start of corticosteroid use between preterm and full-term Duchenne muscular dystrophy males was observed. Overall, the disease course seems to be similar between preterm and full-term males with Duchenne muscular dystrophy; however, pulmonary function seems to be affected earlier among preterm males with Duchenne muscular dystrophy.
APA, Harvard, Vancouver, ISO, and other styles
9

Denetclaw, W. F., G. Bi, D. V. Pham, and R. A. Steinhardt. "Heterokaryon myotubes with normal mouse and Duchenne nuclei exhibit sarcolemmal dystrophin staining and efficient intracellular free calcium control." Molecular Biology of the Cell 4, no. 9 (September 1993): 963–72. http://dx.doi.org/10.1091/mbc.4.9.963.

Full text
Abstract:
Duchenne and mdx muscle tissues lack dystrophin where it normally interacts with glycoproteins in the sarcolemma. Intracellular free calcium ([Ca2+]i) is elevated in Duchenne and mdx myotubes and is correlated with abnormally active calcium-specific leak channels in dystrophic myotubes. We fused Duchenne human and normal mouse myoblasts and identified heterokaryon myotubes by Hoechst 33342 staining to measure the degree to which dystrophin introduced by normal nuclei could incorporate throughout the myotube at the sarcolemma and restore normal calcium homeostasis. Dystrophin expression in myotubes was determined by immunofluorescence and confocal laser scanning microscopy. Dystrophin was expressed at the sarcolemma in normal mouse and heterokaryon myotubes, but not in Duchenne myotubes. In heterokaryons, extensive dystrophin localization occurred at the sarcolemma even where only Duchenne nuclei were present, indicating that dystrophin does not exhibit nuclear domains. Heterokaryon, normal mouse and Duchenne myotube [Ca2+]i was measured using fura-2 and fluorescence ratio imaging. Heterokaryon and normal mouse myotubes were found to maintain similar levels of [Ca2+]i. In contrast, Duchenne myotubes had significantly higher [Ca2+]i (p < 0.001). Furthermore, the ability of heterokaryons to maintain normal [Ca2+]i did not depend on greater numbers of normal nuclei than Duchenne being present in the myotube. These results support the view that dystrophin expression in heterokaryons allows for efficient control of [Ca2+]i.
APA, Harvard, Vancouver, ISO, and other styles
10

Heutinck, Lotte, Nadine van Kampen, Merel Jansen, and Imelda J. M. de Groot. "Physical Activity in Boys With Duchenne Muscular Dystrophy Is Lower and Less Demanding Compared to Healthy Boys." Journal of Child Neurology 32, no. 5 (January 23, 2017): 450–57. http://dx.doi.org/10.1177/0883073816685506.

Full text
Abstract:
This study describes the amount of physical activity and perception of physical activity in boys with Duchenne muscular dystrophy (DMD) compared to healthy boys. A questionnaire described 6 domains of physical activity. Four Duchenne muscular dystrophy subgroups were made: early and late ambulatory, nonambulatory with relative good, or limited arm function. Eighty-four boys with Duchenne muscular dystrophy (15.0 ± 6.4 years) and 198 healthy boys (14.0 ± 4.3 years) participated. Daily activities were more passive for boys with Duchenne muscular dystrophy. Physical activity was less and low demanding compared to healthy boys. It decreased with disease severity ( P < .05), whereas screen time increased ( P < .05). Benefits of physical activity in boys with Duchenne muscular dystrophy were having fun and making friends. Barriers were lack of sport facilities and insufficient health. This study helps to quantify poor engagement in physical activity by boys with Duchenne muscular dystrophy, and demonstrates factors that contribute to it. Suggestions to stimulate physical activity are made.
APA, Harvard, Vancouver, ISO, and other styles
11

Sanadhya, Anuradha, Ritvika Jyani, Suresh Goyal, Neha Asora, and Mukesh Kumar Gurjar. "Duchenne muscular dystrophy in a female with x-autosome translocation." International Journal of Contemporary Pediatrics 8, no. 4 (March 23, 2021): 770. http://dx.doi.org/10.18203/2349-3291.ijcp20211094.

Full text
Abstract:
Duchenne’s muscular dystrophy is the most common hereditary neuromuscular disease, which affects all races. Its classical characteristic clinical features being progressive muscular weakness, intellectual impairment and hypertrophy of the calves with proliferation of connective tissue and progressive fibrosis in muscles. As the disease is inherited as an X-linked recessive trait, thus females not manifesting the disease and acting as carriers only, as second X chromosome prevents the manifestation of disease. We report a case of classical Duchenne muscular dystrophy in 10 year old female with no intellectual deficit and no family history of similar type of muscular dystrophy.
APA, Harvard, Vancouver, ISO, and other styles
12

Robert, D., TN Willig, P. Leger, and J. Paulus. "Long-term nasal ventilation in neuromuscular disorders: report of a consensus conference." European Respiratory Journal 6, no. 4 (April 1, 1993): 599–606. http://dx.doi.org/10.1183/09031936.93.06040599.

Full text
Abstract:
Following the colloquium entitled "Nasal Ventilation and Neuromuscular Disease", which took place in Lyon, France, October 24, 1991, a group of authorities on neuromuscular disorders met to establish a consensus concerning the application of this technique, in the clinical setting, for patients with Duchenne's muscular dystrophy, non-Duchenne myopathies and the spinal muscular atrophies. This report summarizes recommendations issuing from this conference. The conclusions drawn from this work should not be applied to patients with other diagnoses.
APA, Harvard, Vancouver, ISO, and other styles
13

Khatri, Ravi Shankar, Mridul Ranajan, and Shalini . "A COMPARATIVE AYURVEDIC REVIEW OF ETIOPATHOGENESIS OF DUCHENNE MUSCULAR DYSTROPHY (INHERITED DISORDER)." International Journal of Research in Ayurveda and Pharmacy 12, no. 1 (March 2, 2021): 124–25. http://dx.doi.org/10.7897/2277-4343.120127.

Full text
Abstract:
Duchenne muscular dystrophy (DMD) is an inherited disorder with severe progressive muscle weakness. In Ayurveda, Adibala Pravritta Vyadhi are also known as inherited diseases that caused by Matruja beeja dushti (Shonita) and Pitruja beeja dushti (Shukra). Duchenne muscular dystrophy (DMD) has been classified under Adibala Pravritta Vyadhi as per Ayurveda. The main objective of this article is to describe the various aspect of etiopathogenesis of Duchenne muscular dystrophy (DMD) as per Ayurvedic literature. This article will be helpful to making the Nidana (Diagnosis) as per Ayurveda and also help in the Chikitsa (Treatment) of Duchenne muscular dystrophy.
APA, Harvard, Vancouver, ISO, and other styles
14

Melis Gönülal, Melis Gönülal, and Didem Didar Balcı Didem Didar Balcı. "ADALİMUMAB: USAGE İN A CASE WİTH PSORİASİS AND DUCHENNE MUSCULAR DYSTROPHY." INTERNATIONAL JOURNAL OF INNOVATIVE MEDICINE & HEALTHCARE 01, no. 01 (April 1, 2022): 04–07. http://dx.doi.org/10.55858/ijimh01012022-04.

Full text
Abstract:
There are different biological treatments for psoriasis and one of these treatments is adalimumab. Here we want to present a case with psoriasis and Duchenne muscular dystrophy treated with adalimumab. A 23-year-old male patient with psoriasis and Duchenne muscular dystrophy applied to our dermatology clinic. At the sixth week control of the patient we achieved PASI 90 response. Duchenne muscular dystrophy is a rare disease and its coexistence with psoriasis is a very rare status. No similar case report was found in the literature. We wanted to present both this rare status and psoriasis progression under adalimumab treatment. Keywords: psoriasis, adalimumab, Duchenne muscular dystrophy
APA, Harvard, Vancouver, ISO, and other styles
15

Dubey, Abhishek, Gaurav Dubey, Sambodhan Dhawane, and Rishikesh Sharma. "Duchenne Muscular Disease." American Journal of PharmTech Research 8, no. 5 (October 8, 2018): 33–54. http://dx.doi.org/10.46624/ajptr.2018.v8.i5.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Biggar, W. D. "Duchenne Muscular Dystrophy." Pediatrics in Review 27, no. 3 (March 1, 2006): 83–88. http://dx.doi.org/10.1542/pir.27-3-83.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Juříková, Lenka, Zdeňka Bálintová, and Jana Haberlová. "Duchenne muscular dystrophy." Neurologie pro praxi 20, no. 3 (June 12, 2019): 180–82. http://dx.doi.org/10.36290/neu.2019.111.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Kornberg, AndrewJ, and EppieM Yiu. "Duchenne muscular dystrophy." Neurology India 56, no. 3 (2008): 236. http://dx.doi.org/10.4103/0028-3886.43441.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Sussman, Michael. "Duchenne Muscular Dystrophy." Journal of the American Academy of Orthopaedic Surgeons 10, no. 2 (March 2002): 138–51. http://dx.doi.org/10.5435/00124635-200203000-00009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Torreggiani, William C., Iain D. Lyburn, Alison C. Harris, and V. A. Rowley. "Duchenne-Landouzy Dystrophy." American Journal of Roentgenology 174, no. 5 (May 2000): 1467–68. http://dx.doi.org/10.2214/ajr.174.5.1741467a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Millichap, J. Gordon. "Duchenne Muscular Dystrophy." Pediatric Neurology Briefs 3, no. 5 (May 1, 1989): 40. http://dx.doi.org/10.15844/pedneurbriefs-3-5-11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Biggar, W. Douglas. "Duchenne Muscular Dystrophy." Pediatrics In Review 27, no. 3 (March 1, 2006): 83–88. http://dx.doi.org/10.1542/pir.27.3.83.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Bushby, K. "Duchenne Muscular Dystrophy." Journal of Medical Genetics 31, no. 6 (June 1, 1994): 506. http://dx.doi.org/10.1136/jmg.31.6.506.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Bundey, S. "Duchenne Muscular Dystrophy." Journal of Medical Genetics 25, no. 2 (February 1, 1988): 140. http://dx.doi.org/10.1136/jmg.25.2.140.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Bundey, S. "Duchenne Muscular Dystrophy." Journal of Medical Genetics 26, no. 6 (June 1, 1989): 416. http://dx.doi.org/10.1136/jmg.26.6.416.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Heckmatt, J. Z. "Duchenne Muscular Dystrophy." Archives of Disease in Childhood 64, no. 5 (May 1, 1989): 767. http://dx.doi.org/10.1136/adc.64.5.767.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

McDonald, Craig M., Richard T. Abresch, Gregory T. Carter, William M. Fowler, E. Ralph Johnson, David D. Kilmer, and Barbara J. Sigford. "Duchenne Muscular Dystrophy." American Journal of Physical Medicine & Rehabilitation 74, Supplement 1 (September 1995): S70—S92. http://dx.doi.org/10.1097/00002060-199509001-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Gomez-Merino, Elia, and John R. Bach. "Duchenne Muscular Dystrophy." American Journal of Physical Medicine & Rehabilitation 81, no. 6 (June 2002): 411–15. http://dx.doi.org/10.1097/00002060-200206000-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Harper, P. "Duchenne Muscular Dystrophy." Journal of Neurology, Neurosurgery & Psychiatry 50, no. 9 (September 1, 1987): 1249. http://dx.doi.org/10.1136/jnnp.50.9.1249.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Marles, Hugh C. "Duchenne de Boulogne." History of Photography 16, no. 4 (December 1992): 395–96. http://dx.doi.org/10.1080/03087298.1992.10442576.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Scott, Oona M. "Duchenne Muscular Dystrophy." Physiotherapy 76, no. 3 (March 1990): 138. http://dx.doi.org/10.1016/s0031-9406(10)62140-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Villanova, Marcello, Beatrice Brancalion, and Anokhi D. Mehta. "Duchenne Muscular Dystrophy." American Journal of Physical Medicine & Rehabilitation 93, no. 7 (July 2014): 595–99. http://dx.doi.org/10.1097/phm.0000000000000074.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Shieh, Perry B. "Duchenne muscular dystrophy." Current Opinion in Neurology 28, no. 5 (October 2015): 542–46. http://dx.doi.org/10.1097/wco.0000000000000243.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Roper, Helen P. "Duchenne muscular dystrophy." Neuromuscular Disorders 14, no. 5 (May 2004): 346–47. http://dx.doi.org/10.1016/j.nmd.2004.02.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Davies, Kay E. "Duchenne muscular dystrophy." Trends in Genetics 3 (January 1987): 231–32. http://dx.doi.org/10.1016/0168-9525(87)90244-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Topaloglu, Haluk. "Duchenne Muscular Dystrophy." European Journal of Paediatric Neurology 8, no. 5 (September 2004): 269. http://dx.doi.org/10.1016/j.ejpn.2004.05.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Bolhuis, P. A. "Duchenne muscular dystrophy." Journal of the Neurological Sciences 80, no. 1 (August 1987): 118–19. http://dx.doi.org/10.1016/0022-510x(87)90230-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Bolhuis, P. A. "Duchenne muscular dystrophy." Journal of the Neurological Sciences 90, no. 3 (May 1989): 348. http://dx.doi.org/10.1016/0022-510x(89)90125-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Samson, Kurt. "DUCHENNE MUSCULAR DYSTROPHY." Neurology Today 3, no. 9 (September 2003): 1. http://dx.doi.org/10.1097/00132985-200309000-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Casademont, Jordi. "Duchenne Muscular Dystrophy." Clinical Neurophysiology 115, no. 10 (October 2004): 2426. http://dx.doi.org/10.1016/j.clinph.2004.05.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

COMTET, J. J., L. SEDEL, J. F. FREDENUCCI, and G. HERZBERG. "Duchenne-Erb Palsy." Clinical Orthopaedics and Related Research &NA;, no. 237 (December 1988): 17???23. http://dx.doi.org/10.1097/00003086-198812000-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Bach, John R., Daniel Martinez, and Bilal Saulat. "Duchenne Muscular Dystrophy." American Journal of Physical Medicine & Rehabilitation 89, no. 8 (August 2010): 620–24. http://dx.doi.org/10.1097/phm.0b013e3181e72207.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Spies, S., K. Schipper, F. Nollet, and T. A. Abma. "Duchenne muscular dystrophy." BMJ 341, sep07 1 (September 7, 2010): c4364. http://dx.doi.org/10.1136/bmj.c4364.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

von Moers, A. "Muskeldystrophie Typ Duchenne." Nervenheilkunde 30, no. 10 (2011): 805–12. http://dx.doi.org/10.1055/s-0038-1628428.

Full text
Abstract:
ZusammenfassungDie Muskeldystrophie Duchenne ist eine X-gebundene rezessive Erkrankung, die bei 1:3 500 Knaben auftritt. Sie wird durch Mutationen im DMD-Gen verursacht. Die Mutationen resultieren in einem Verlust von Dystrophin, dies führt zur progredienten Muskeldegeneration. Der Krankheitsverlauf ist durch eine progrediente, proximal betonte Muskelschwäche gekennzeichnet, die ohne Behandlung zu einem Gehverlust um das 10. Lebensjahr und zum frühzeitigen Tod um das 20. Lebensjahr durch Ateminsuffizienz oder Herzversagen führt. Durch symptomatische Therapien kann der Krankheitsverlauf positiv beeinflusst werden, besonders durch die Etablierung der nicht invasiven Beatmung konnte die Lebenserwartung erheblich verlängert werden. In den letzten Jahren wurden verschiedene Ansätze einer kausalen Therapie untersucht. Am weitesten gediehen ist das “exon skipping”, dessen Wirksamkeit in internationalen, multizentrischen Phase-III Studien untersucht wird.
APA, Harvard, Vancouver, ISO, and other styles
45

Behera, V., M. K. Behera, R. Chauhan, and V. Nair. "Duchenne muscular dystrophy." Case Reports 2014, jun10 1 (June 10, 2014): bcr2014205296. http://dx.doi.org/10.1136/bcr-2014-205296.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

ISHIKAWA, Y., J. R. BACH;, and A. K. SIMONDS. "Duchenne muscular dystrophy." Thorax 54, no. 6 (June 1, 1999): 562. http://dx.doi.org/10.1136/thx.54.6.562c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Yiu, Eppie M., and Andrew J. Kornberg. "Duchenne muscular dystrophy." Journal of Paediatrics and Child Health 51, no. 8 (March 9, 2015): 759–64. http://dx.doi.org/10.1111/jpc.12868.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Rifai, Z. "Duchenne Muscular Dystrophy." Archives of Neurology 51, no. 9 (September 1, 1994): 846. http://dx.doi.org/10.1001/archneur.1994.00540210016003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Hyser, C. "Duchenne Muscular Dystrophy." Archives of Neurology 45, no. 4 (April 1, 1988): 369. http://dx.doi.org/10.1001/archneur.1988.00520280011003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Chamberlain, Jeffrey S. "Duchenne muscular dystrophy." Current Opinion in Genetics & Development 1, no. 1 (June 1991): 11–14. http://dx.doi.org/10.1016/0959-437x(91)80033-i.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Duchenne' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography